The University of Texas Medical Branch has completed a research study in 2014 to examine the links between testosterone use and risks of Cardiovascular events or Myocardial Infarction. The study aimed to look more closely at these issues following a January, 2014 study we previously posted that came to different conclusions. This more recent study concludes stated that: “Older men who were treated with intramuscular testosterone did not appear to have an increased risk of MI. For men with high MI risk, testosterone use was modestly protective against MI”.
This new matched double cohort study assessed more than 24,000 Medicare beneficiaries using intramuscular testosterone therapy and showed that a dose-response analysis demonstrated no increased risk in MI. These findings were robust across eligibility criteria, exposure thresholds, follow-up periods, and covariate adjustment. On April 29, we published a blog entry called “Increased Risk of Non-Fatal Myocardial Infraction Following Testosterone Therapy Prescription in Men” published by the PlosOne online journal from January of 2014. That day we also published the group petition by world experts analyzing that study and seeking for JAMA to retract their study. This July 2014 assesses many of the same risks presented in that January study and comes to a different conclusion presented here. We present all of these separate analysis and discussions for you and your personal physician to understand and assess your risks of heart issues with testosterone therapy.
Hormone Therapeutics July 16th, 2014
Posted In: Health & Wellness
Tags: cardiovascular events, effects of testosterone, heart issues, intramuscular testosterone, low t, low testosterone, myocardial infarction, older men, research study, risks of testosterone, testosterone, testosterone therapy, university of texas